Neutralizing Antibodies to Human Cytomegalovirus Recombinant Proteins Reduce Infection in an Ex Vivo Model of Developing Human Placentas

Human cytomegalovirus (HCMV) is the leading viral cause of congenital disease and permanent birth defects worldwide. Although the development of an effective vaccine is a public health priority, no vaccines are approved. Among the major antigenic targets are glycoproteins in the virion envelope, inc...

Descripción completa

Detalles Bibliográficos

Autores principales:	Takako Tabata, Matthew Petitt, Julia Li, Xiaoyuan Chi, Wei Chen, Irina Yurgelonis, Sabine Wellnitz, Simon Bredl, Tiago Vicente, Xinzhen Yang, Philip R. Dormitzer, Lenore Pereira
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2022-07-01
Colección:	Vaccines
Materias:	cytomegalovirus vaccine congenital infection placenta
Acceso en línea:	https://www.mdpi.com/2076-393X/10/7/1074
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!